Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131875) titled 'Mifepristone Versus Dienogest in the Treatment of Adenomyosis: A Retrospective Cohort Study' on Sept. 7.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Adenomyosis
Intervention:
Mifepristone Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-10
Target Sample Size: Mifepristone Group:35;Dienogest Group:35;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342134
Published by HT Digital Content Services with permission from Health Daily D...